In the next 15 years, where are the major varieties of Chinese medicine?

Recently, the institutional design of the Chinese medicine industry is quite "foot-leap" with a tight pace. The evening of February 26 was officially unveiled. The General Office of the State Council announced on the same night that it had published the "Outline of the Strategic Plan for the Development of Chinese Medicine (2016-2030)". Note that this is a national-level strategic outline for Chinese medicine. The document provides a detailed guide to the compass for the development of Chinese medicine in the next 15 years. The Chinese medicine industry once again stands in the air.

The "Plan" clearly stated that by 2020, everyone will basically enjoy the services of Chinese medicine, and the Chinese medicine industry will become one of the important pillars of the national economy. By 2030, the full coverage of the field of Chinese medicine services will be realized, and the capacity for Chinese medicine's health services will be significantly enhanced. Make greater contributions to economic and social development. Conscientiously comprehending the spirit of this heavyweight document, the reporter noted that the document uses the words “urgently needed” and “to develop it as an important pillar of the national economy” for the development of Chinese medicine. These words reveal that in the coming 15 years, It is a new period of strategic opportunities for Chinese medicine companies. After sorting out the contents of the documents, we have found that in the next fifteen years, upgrading of the Chinese medicine industry will become one of the main melody. Then, where is the direction of improving the quality and efficiency of the Chinese medicine industry? The reporter sorted out this and invited relevant experts to make in-depth interpretations.

Policy highlights:

Promote the transformation and upgrading of Chinese medicine industry

Promote the digitalization, networking, and intelligent construction of the Chinese medicine industry, strengthen technology integration and process innovation, improve the level of manufacturing of traditional Chinese medicine equipment, accelerate the standardization and modernization of Chinese medicine production processes and processes, improve the ability of Chinese medicine industry in the use of intellectual property, and gradually form a large-scale Chinese medicine enterprise group And industrial clusters. Relying on the modernization of science and technology industry base of traditional Chinese medicine, we will implement the action of science and technology entrepreneurs in the great health industry of Chinese medicine, and promote the integration and development of the 12 industries of traditional Chinese medicine. After the launch of proprietary Chinese medicines, the company will launch a large-scale, standardized clinical trial and cultivate a batch of famous generic drugs with international competitiveness. Develop a batch of Chinese medicine manufacturing machinery and equipment to improve the technical level and economies of scale of Chinese medicine manufacturing. We will promote the implementation of the Action Plan for the Standardization of Traditional Chinese Medicines, establish a quality product standard system for the whole chain of the Chinese medicine industry, and establish a green manufacturing system for Chinese medicine.

Viewpoint collision OPINION

Member of the 10th National Pharmacopoeia Committee, Chairman of the Chinese Herbal Medicine Professional Committee of the Chinese Medicine Association, and Jiang Yun, Chairman of Sichuan Xinhuahua Herbal Pieces Co., Ltd.: The Chinese medicine industry will enter the era of true quality competition. Taking traditional Chinese medicine decoction pieces as an example, in the past, there was a lack of standards for decoction pieces, the concentration was not high, and there were some vacancies in supervision. With the continuous improvement and improvement of pharmacopoeia standards, the regulatory level has become more and more stringent, and it is not difficult to judge that the future of Chinese medicine will enter the real world. The age of quality competition. The premise of this market increase is that the government must continue to strengthen strict and high standards of supervision, establish platforms and rules, and create a sound and sustainable environment of fair competition. This is particularly important. For enterprises, it is the technical upgrading, such as the quality control of the source of medicinal materials and the improvement of production techniques such as concoction.

Senior Expert of the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences: The evolutionary strategy is to practice the “Three Goods Strategy”. This plan is a major benefit to the Chinese medicine industry. It not only embodies the high level of attention at the national level, but also indicates the direction of the orientation and development of the industry. At the same time, the document also takes into account the two markets and implements the internationalization of Chinese medicine under the “One Belt One Road” strategy. The basis of all this is to have a high quality and effective supply. In accordance with the requirements of supply-side reform, the Chinese medicine industry must firmly adopt the three-product strategy: increase variety, improve quality, create brand, and enterprises must accelerate changes in adapting to market demand. There will be a brand-new layout at the national level, which will be reflected in safeguard measures such as the Chinese Medicine Law in the future. From the perspective of enterprises, it is necessary to improve the service quality of Chinese medicine. What is now embarrassing is that some traditional Chinese medicine services are provided abroad, which reflects the urgency of industrial development. The Chinese medicine industry is improving quality and efficiency. As an industry, it is necessary to cultivate large varieties and achieve controllable quality. Only when the industry is bigger, will there be large enterprises with high quality, and only the high-quality enterprises will become stronger and bigger. Develop more quality and large varieties.

The State Intellectual Property Office Patent Office former Minister of Pharmaceutical Biology Invention Review Zhang Qingkui: Patent protection of Chinese medicine varieties is the most powerful support for risk prevention. At present, many traditional Chinese medicine products are sales-oriented, with large investment in the market, but their enthusiasm for research and development and patent applications is weak. Enterprises are more willing to do some policy applications, and the use of geographical indications to protect rare medicinal herbs, as well as the protection of ancestral secrets itself is also very difficult. Although administrative protection has promoted the development of traditional Chinese medicine within a certain period of time, it can be concluded that such protection will gradually weaken in the future, and if there is no way out without innovation, the current growth model will not be changed, and the market will be even more difficult to expand. It is difficult to reconcile the protection system of traditional Chinese medicine varieties and the tendering and procurement system for medicines. How can the potential varieties have market exclusivity? Such as Liuwei Dihuang Wan manufacturers many, how does it grow? In fact, the protection of Chinese medicine varieties does not possess the unique rights and interests of patent protection, and the legal status of the Patent Law is even higher. Chinese enterprises should take the initiative to highlight their swords, make efforts to formulate examination standards for Chinese medicine patents, and gradually implement them throughout the world, and increase judicial protection to obtain the initiative to formulate Chinese medicine evaluation systems.

link:

The pattern of large varieties of Chinese medicine

From the perspective of the current size of Chinese medicine companies, large-scale, medium-sized, and small-sized enterprises are pyramidally distributed. The majority of small and medium-sized enterprises account for about three quarters of the entire Chinese medicine industry. As for these large-scale traditional Chinese medicine companies that are at the top of the pyramid, there are currently large varieties of mature products under development and sales, such as Danhong Injection of Buchang Pharmaceutical, Xueshuantong Injection of Guangxi Wuzhou Pharmaceutical, and Compound Danshen Dripping Pill of Tianjin Tasly. Wait. However, because the country does not have an overall industrial plan, the structure of the Chinese medicine industry is irrational and blind development has occurred. At present, there are more than 2,000 TCM manufacturing companies and less than 5% of large-scale enterprises. The overall situation is “small, scattered, chaotic, and poor”. The quality of products is unevenly developed, and market competition has mainly driven down the old path of price vicious competition, which has seriously hampered the progress and development of the entire industry. For these large-scale traditional Chinese medicine companies currently in the market, they have great advantages in market, talent, technology, and capital. They already have varieties of high sales, and marketing channels and customer markets have been relatively stable after years of development.

Policy highlights:

Expand International Trade in Traditional Chinese Medicine

Integrate international trade in TCM into the overall strategy for the development of foreign trade of the country, establish a policy support system, break through the legal and policy barriers and technical barriers that restrict the development of TCM's foreign trade overseas, strengthen international protection of TCM IPR, and expand the international market for TCM service trade Access. Support Chinese medicine institutions to participate in the construction of the “One Belt and One Road” and expand the foreign investment and trade of Chinese medicine.

Meng Dongping, vice chairman of the Chinese Medical Insurance Chamber of Commerce: There has been a period of denial of the voice of traditional Chinese medicine in the past. The country mentioned the strategic height of Chinese medicine, not only refuting these negative voices, but also forming a time of day, geography, Human and Chinese medicine industry environment. We know that the international recognition of Chinese medicine still needs to create a better atmosphere and create a platform for the traditional Chinese medicine to integrate into the modern technology concept and go out better. This is not an overnight event. It is clear that we must make the country more widely recognized. It is necessary to pay more attention to the feelings of the importing countries. Now that many large-scale Chinese medicine companies have expressed strong international demands when they come into contact with us, then how policies and markets, governments and enterprises need to work together to find a way out. Our association is also doing some exploration, such as advancing Chinese medicine in the free trade zone and so on.

Another point worth noting is that the country has promoted the upgrading of Chinese medicine services from health care to medical rehabilitation in all directions, and medical services have focused on the treatment of diseases, the maintenance of health care, the development of treatment of diseases, and the rehabilitation of elderly services. My point is that in order to form the leading force for Chinese medicine to go global, it is necessary to work hard on traditional cultural identity and technological upgrading to improve the quality and service experience. Although acupuncture and moxibustion have been included in the Medicare reimbursement system in the United States, it is very important. With limited, the next step is to promote more high-quality Chinese medicine companies into the international market through institutional promotion. Now the prospects of regional development in Southeast Asia with high cultural recognition of Chinese medicine have performed well, and there is a wider international market that needs to be expanded. This requires the convergence of arrangements and policies at the institutional level to form a joint force for going global. In the future, the trend of international competition will intensify. It is not sufficient for companies to go it alone, but it still depends on institutional and institutional arrangements and guarantees.

Policy highlights:

Effectively improve the ability of TCM medical services

? Local people's governments at and above the county level shall rationally allocate medical resources for Chinese medicine in the regional health plans. In principle, one municipal office-administered Chinese medicine hospital and one county-administered Chinese medicine hospital shall be set up in each prefecture-level regional and county-level region. Hospitals, maternal and child health institutions and other non-Chinese medical institutions set up Chinese medicine departments. In the township health centers and community health service centers, TCM clinics, national doctors’ clinics, and other comprehensive Chinese medicine service areas are established to strengthen the allocation of Chinese medicine equipment and the staffing of Chinese medicine. Relaxation of access to Chinese medicine services.

To improve the ability of traditional Chinese medicines for the diagnosis and treatment of dominant diseases of traditional Chinese medicine and comprehensive service capabilities of traditional Chinese medicine in county-level TCM hospitals and primary-level medical and health institutions. Establish a system for the monitoring and information management of chronic diseases with Chinese medicine, promote the establishment of a community health management model that incorporates the content of Chinese medicine, carry out health interventions for high-risk groups with Chinese medicine, and promote the level of grass-roots Chinese medicine health management. We will vigorously develop non-drug therapies for Chinese medicine and give full play to its unique role in the prevention of common diseases, frequently-occurring diseases, and chronic diseases.

Jiang Yun: We think that the outline of this plan is very high, and the Chinese medicine industry has been elevated to the national strategic level. The wording of the document can also feel this force. The Chinese medicine industry is greatly encouraged. I am particularly concerned about some of the detailed arrangements mentioned in the document, such as the construction of county-level TCM hospitals, and township hospitals to build an integrated service agency such as a Chinese medicine hospital. This means that TCM's service will become more in-depth and convenient in the future. Behind it lies a huge market space.

Policy highlights:

Improve the coverage of TCM medical service network in urban and rural areas

Completely build a TCM medical service network with TCM hospitals as the mainstay, general hospitals and other types of hospital TCM departments as the backbone, basic medical and health institutions, and TCM clinics and clinics as supplements to cover TCM medical services in urban and rural areas. Improve the ability of Chinese medicine to prevent and cure diseases. Promote "Internet +" Chinese medicine.

Senior Expert of the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences: In the field of traditional Chinese medicine, we must clarify goals, clarify ideas, highlight priorities, and strive to achieve better development through the organic combination of innovative ideas and innovative methods in improving clinical curative effect and academic level. And promotion. Exploring the Internet to extend the use of online medical services such as doctor's orders and electronic prescriptions indicates that traditional Chinese medicine will obtain electronic prescriptions from the Internet, which will play a role in promoting the lifting of online sales of prescription drugs. If the promotion of medical services from the focus on disease treatment to focus on the direction of health care can be implemented, the future of geriatric disease, chronic disease prevention and rehabilitation care will be more and more hot. In this way, enterprises in the distribution of medicinal materials, extracting raw materials, preparations, end markets, and telemedicine will have a stronger ability to compete. After all, judging from the attitude of the state pushing Chinese medicine, the amount of Chinese medicine used in the future will be The proportion of medical drugs will increase. Those quality Chinese medicines with evidence of evidence-based medicine will stand out, while some small and medium-sized enterprises will withdraw from the market. The Chinese medicine industry will develop in the direction of scale and intensification.

Judging from the contents of the documents, the national plan emphasizes the concept of systematic and full industrial chain. Subsequent ministries and commissions will further formulate concrete implementation plans based on this outline and implement them one by one worthy of the medical community’s high concern.